Organization’s Research Arm Will Use System to Improve Accrual of Data Collection, Validation, Reporting in Prostate Cancer Study
SAN DIEGO--(BUSINESS WIRE)--VisionTree®, the leader in Web-based patient-centered health record management and provider communication systems, announced today that the Radiation Therapy Oncology Group (RTOG) through the American College of Radiology selected its VisionTree Optimal Care™ (VTOC) platform for collecting quality of life patient outcomes data for a pilot study conducted by the RTOG. RTOG will use the system at a select number of member institutions for a prostate cancer study in order to improve the compliance of the data collection, validation and reporting processes.
“Clinical research typically has its greatest challenges in collecting patient-completed information, since it is usually done through a paper or phone survey,” said Benjamin Movsas, M.D., Chair of Radiation Oncology at Detroit’s Henry Ford Hospital and Principal Investigator of an RTOG pilot study testing the VTOC system. “VTOC offers us the ability to move this process to an electronic format through a secure Web portal to collect data in a faster and more compliant manner. The platform also allows us to deliver relevant information to the patient including reminders, education material and study information more effectively in order to manage their treatment. VTOC is a system whose time has come.”
VTOC’s user-friendly, HIPAA-secure, Web-based platform allows consenting patients to fill out their quality of life forms in real-time from any location that has Internet access, including their home. The system can also send patients reminders via e-mail or text messaging to increase the likelihood of their on-going participation.
press release >> http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20080115006134&newsLang=en
Tuesday, January 15, 2008
Radiation Therapy Oncology Group (RTOG) Selects VisionTree Optimal Care™ to Collect Quality of Life Patient Outcomes Data
Posted by www.med-centric.com at 8:21 PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment